A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01) A61K 9/19 (2006.01) A61K 47/26 (2006.01) A61K 47/34 (2006.01)
Patent
CA 2691855
The present invention relates generally to the field of pharmaceutical formulation of immunoglobulins. Specifically, the present invention relates to stable, lyophilized, high concentration immunoglobulin formulations. This invention is exemplified by a stabilized lyophilized formulation of the recombinant humanized anti- alpha-4 integrin antibody natalizumab.
La présente invention concerne d'une manière générale le domaine des formulations pharmaceutiques d'immunoglobulines. Plus spécifiquement, la présente invention concerne des formulations d'immunoglobuline à haute concentration, stables et lyophilisées. Cette invention concerne par exemple une formulation lyophilisée stabilisée du natalizumab, un anticorps de l'intégrine anti-alpha-4 humanisé recombinant.
Buckley Shaun E.
Burke David J.
Lehrman Sherwood Russ
O'connor Barbara Horsey
Elan Pharmaceuticals Inc.
Ledgley Law
LandOfFree
Lyophilized immunoglobulin formulations and methods of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Lyophilized immunoglobulin formulations and methods of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lyophilized immunoglobulin formulations and methods of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1355960